Matching trials
1,853 results
- CheckMate-017Independent statistical analysis of CheckMate-017, the randomized phase 3 trial of nivolumab versus docetaxel in previously treated advanced or metastatic squamous cell non-small cell lung cancer, including its overall-survival analysis and statistical…
- CheckMate-026Independent statistical analysis of CheckMate-026, a randomized phase 3 trial of nivolumab versus investigator's choice chemotherapy as first-line therapy for stage IV or recurrent PD-L1+ non-small cell lung cancer.
- CheckMate-141Independent statistical analysis of CheckMate-141, the randomized phase 3 trial of nivolumab versus investigator's choice therapy in recurrent or metastatic squamous cell carcinoma of the head and neck.
- CheckMate-816Independent statistical analysis of CheckMate-816, a randomized phase 3 trial of nivolumab plus platinum-doublet chemotherapy versus chemotherapy alone in early-stage non-small cell lung cancer.
- CheckMate-9DWIndependent statistical analysis of CheckMate-9DW, a phase 3 randomized trial evaluating nivolumab plus ipilimumab versus sorafenib or lenvatinib in advanced hepatocellular carcinoma.
- CheckMate901A detailed statistical analysis of CheckMate901, a randomized phase 3 trial evaluating nivolumab, ipilimumab, and standard chemotherapy in untreated inoperable or metastatic urothelial cancer.
- CHEST-2Independent statistical analysis of CHEST-2, a phase 3 long-term extension study of riociguat in patients with pulmonary hypertension, including trial design, registered endpoints, safety results, planned statistical interpretation, and methodological context.
- CHOICESIndependent statistical analysis of Comparing Treatments for HIV-Infected Opioid and Alcohol Users in an Integrated Care Effectiveness Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- CHOOSEIndependent statistical analysis of Cross Over Convenience And Preference Study Of New Mark VII Compared To Genotropin Pen In Pediatric And Adult Subjects: primary endpoint results, effect estimate with confidence interval, sample-size…
- CHRONICLEIndependent statistical analysis of A 1-year Trial to Inform About Long-term Exposure to Eptinezumab in Participants With Chronic Cluster Headache (cCH): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Cinnamon Extract on Menstrual Cycles in PolyCystic Ovary Syndrome (PCOS): Complete Statistical AnalysisIndependent statistical analysis of Cinnamon Extract on Menstrual Cycles in PolyCystic Ovary Syndrome (PCOS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01483118).
- CIRCULATE-USAn independent statistical analysis of CIRCULATE-US (NCT05174169), a randomized phase 2/3 trial evaluating adjuvant chemotherapy strategies based on residual disease assessment in stage III colon cancer.
- Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery: Complete Statistical AnalysisIndependent statistical analysis of Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- CIRTIndependent statistical analysis of Cardiovascular Inflammation Reduction Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01594333).
- Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer: Complete Statistical AnalysisIndependent statistical analysis of Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- CLARITYIndependent statistical analysis of A Safety and Efficacy Study of Oral Cladribine in Subjects With Relapsing-remitting Multiple Sclerosis (RRMS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- CLARITY ADIndependent statistical analysis of the phase 3 CLARITY AD trial of lecanemab in participants with early Alzheimer's disease, covering trial design, CDR-SB endpoints, safety endpoints, planned statistical analysis, and interpretation.
- CLARITY-TIMI 28Independent statistical analysis and educational interpretation of CLARITY-TIMI 28, a randomized phase 3 trial evaluating clopidogrel as adjunctive reperfusion therapy in acute coronary syndromes.
- CLASSICIndependent statistical analysis of the CLASSIC phase 3 trial evaluating capecitabine and oxaliplatin as adjuvant therapy for stomach cancer, including trial design, endpoints, statistical methodology, and interpretation.
- CLASSICIIIndependent statistical analysis of Remission in Subjects With Crohn's Disease, 1 Year Phase: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00055497).
- CLEARIndependent statistical analysis of Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- CLEAR 2Independent statistical analysis of Combining Lesinurad With Allopurinol in Inadequate Responders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01493531).
- CLEAR OutcomesIndependent statistical analysis of CLEAR Outcomes, the randomized phase 3 trial of bempedoic acid versus placebo in statin-intolerant participants with or at high risk for cardiovascular disease, including MACE, secondary time-to-event endpoints,…
- CLEAR SYNERGYIndependent statistical analysis of CLEAR SYNERGY, a randomized phase 3 factorial trial evaluating colchicine and spironolactone strategies in patients with ST elevation or non-ST elevation myocardial infarction, including its primary endpoints, trial…
- CLEOPATRAIndependent statistical analysis of CLEOPATRA, the randomized phase 3 trial of pertuzumab plus trastuzumab and docetaxel versus placebo plus trastuzumab and docetaxel in previously untreated HER2-positive metastatic breast cancer.
- CLEVERIndependent statistical analysis of Efficacy and Safety of Clesrovimab (MK-1654) in Infants (MK-1654-004): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04767373).
- Clinical and Microbial Efficacy of Besifloxacin Ophthalmic Suspension, 0.6% in the Treatment of Bacterial Conjunctivitis: Complete Statistical AnalysisIndependent statistical analysis of Clinical and Microbial Efficacy of Besifloxacin Ophthalmic Suspension, 0.6% in the Treatment of Bacterial Conjunctivitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Clinical Evaluation of Ropinirole Prolonged Release/Extended Release (PR/XR) Tablet for Adjunctive Therapy to L-dopa in Subjects With Advanced Parkinson’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Clinical Evaluation of Ropinirole Prolonged Release/Extended Release (PR/XR) Tablet for Adjunctive Therapy to L-dopa in Subjects With Advanced Parkinson's Disease: primary endpoint results, effect estimate with confidence interval,…
- Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma: Complete Statistical AnalysisIndependent statistical analysis of Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Clinical Study of Efficacy and Safety of Raphamin in the Treatment of ARVI in Children 12-18 Years Old: Complete Statistical AnalysisIndependent statistical analysis of Clinical Study of Efficacy and Safety of Raphamin in the Treatment of ARVI in Children 12-18 Years Old: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Clinical Study of Lamotrigine to Treat Newly Diagnosed Epilepsy: Complete Statistical AnalysisIndependent statistical analysis of Clinical Study of Lamotrigine to Treat Newly Diagnosed Epilepsy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01431963).
- Clinical Study of the Immunogenicity of GSK Biologicals’ Influenza Vaccine GSK2186877A in People Aged 65 Years or Older: Complete Statistical AnalysisIndependent statistical analysis of Clinical Study of the Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in People Aged 65 Years or Older: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Clinical Study to Assess the Efficacy and Safety of G238 Compared to Clotrimazole Otic Solution in the Treatment of Otomycosis: Complete Statistical AnalysisIndependent statistical analysis of Clinical Study to Assess the Efficacy and Safety of G238 Compared to Clotrimazole Otic Solution in the Treatment of Otomycosis: primary endpoint results, effect estimate with confidence interval,…
- Clinical Study to Evaluate the Safety, Immunogenicity and Efficacy of Investigational Flu Vaccine Compared to Approved Flu Vaccine in Children.: Complete Statistical AnalysisIndependent statistical analysis of Clinical Study to Evaluate the Safety, Immunogenicity and Efficacy of Investigational Flu Vaccine Compared to Approved Flu Vaccine in Children.: primary endpoint results, effect estimate with confidence interval,…
- Clinical Study to Evaluate the Therapeutic Equivalence of Ketoconazole Cream 2% in the Treatment of Tinea Pedis: Complete Statistical AnalysisIndependent statistical analysis of Clinical Study to Evaluate the Therapeutic Equivalence of Ketoconazole Cream 2% in the Treatment of Tinea Pedis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Clinical Trial of CNS-targeted HAART (CIT2): Complete Statistical AnalysisIndependent statistical analysis of Clinical Trial of CNS-targeted HAART (CIT2): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00624195).
- Clinical Trial of Efficacy and Safety of Prospekta in the Treatment of Attention Deficit/Hyperactivity Disorder in Children: Complete Statistical AnalysisIndependent statistical analysis of Clinical Trial of Efficacy and Safety of Prospekta in the Treatment of Attention Deficit/Hyperactivity Disorder in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Clinical Trial of Standard Versus Goal-Directed Perioperative Fluid Management (GDT) for Patients Undergoing Liver Resection: Complete Statistical AnalysisIndependent statistical analysis of Clinical Trial of Standard Versus Goal-Directed Perioperative Fluid Management (GDT) for Patients Undergoing Liver Resection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Clinical Trial to Assess the Efficacy and Safety of ‘Immuncell-LC’ With Temozolomide in Newly Diagnosed Glioblastoma of Korea: Complete Statistical AnalysisIndependent statistical analysis of Clinical Trial to Assess the Efficacy and Safety of 'Immuncell-LC' With Temozolomide in Newly Diagnosed Glioblastoma of Korea: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- CLL11: A Study of Obinutuzumab (RO5072759 [GA101]) With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia (Stage 1a): Complete Statistical AnalysisIndependent statistical analysis of CLL11: A Study of Obinutuzumab (RO5072759 [GA101]) With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia (Stage 1a): primary endpoint results, effect estimate with confidence interval, sample-size…
- Clodronate With or Without Chemotherapy and/or Hormonal Therapy in Treating Women With Stage I or Stage II Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Clodronate With or Without Chemotherapy and/or Hormonal Therapy in Treating Women With Stage I or Stage II Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size…
- CLOSEA statistical analysis of the CLOSE phase 3 trial evaluating patent foramen ovale closure or anticoagulants versus antiplatelet therapy to prevent stroke recurrence.
- CLOTS 3Independent statistical analysis of CLOTS 3 (NCT00789542), a phase 3 randomized trial evaluating intermittent pneumatic compression to prevent post-stroke deep vein thrombosis.
- COASTIndependent statistical analysis of OPT-302 With Aflibercept in Neovascular Age-related Macular Degeneration (nAMD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04757636).
- COAST-VIndependent statistical analysis of A Study of Ixekizumab (LY2439821) in bDMARD-Naive Participants With Radiographic Axial Spondyloarthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- CodeBreaK 200Independent statistical analysis of CodeBreaK 200, a randomized phase 3 trial comparing AMG 510 (sotorasib) with docetaxel in KRAS G12C-mutated advanced or metastatic NSCLC, including progression-free survival, hazard ratios, confidence intervals, log-rank…
- Cognitive Remediation With D-Cycloserine: Complete Statistical AnalysisIndependent statistical analysis of Cognitive Remediation With D-Cycloserine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01399866).
- COLUMBUSIndependent statistical analysis of the COLUMBUS phase 3 trial of LGX818 plus MEK162, vemurafenib, and LGX818 monotherapy in BRAF mutant melanoma, including trial design, registered PFS endpoints, planned survival analysis, and safety…
- Combination Antibiotic Treatment for Reactive Arthritis Caused by Chlamydia Bacteria: Complete Statistical AnalysisIndependent statistical analysis of Combination Antibiotic Treatment for Reactive Arthritis Caused by Chlamydia Bacteria: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00351273).
- Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors: Complete Statistical AnalysisIndependent statistical analysis of Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…